This is an online resource of psychedelic research literature organized by substances and medical conditions. We have prioritized conditions that have been approved for authorization to access psychedelic substances under Canada’s Special Access Program (SAP). Designed for healthcare practitioners and patients preparing SAP applications, it also serves as an accessible resource for anyone interested in the clinical evidence surrounding psychedelic therapies.